Clinical Trials Browser

Phase 2 × Non-small Cell Lung Cancer Metastatic × dacomitinib × Clear all

NCT04504071 2025-09-08

Dacomitinib in Lung Cancer With Uncommon EGFR Mutations

Phase 2 Active not recruiting

Non-small Cell Lung Cancer Metastatic